Ventas/$VTR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Ventas

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Ticker

$VTR

Primary listing

NYSE

Employees

498

Ventas Metrics

BasicAdvanced
$31B
156.97
$0.43
0.89
$1.86
2.85%

What the Analysts think about Ventas

Analyst ratings (Buy, Hold, Sell) for Ventas stock.

Bulls say / Bears say

Ventas’s diversified healthcare portfolio of nearly 1,400 properties across senior housing, medical office, hospitals, and life science assets spreads risk and provides stable, multi-segment cash flows (Reuters).
Investors assign a premium to Ventas’s asset quality and growth prospects, as evidenced by its price-to-book ratio of 2.66 times, well above sector averages (Reuters).
Ventas generated $1.12 billion in operating cash flow in the latest reported period, highlighting its strong cash generation capacity to support dividends and reinvestment (Reuters).
High leverage exposes Ventas to rising interest costs, with total debt of $13.5 billion representing over 54 percent of its $24.7 billion asset base (Reuters).
U.S. REIT sector trades at a price-to-net asset value multiple of 3.8, well above its historical average of less than 2.5, raising the risk of valuation compression if market sentiment shifts (Reuters).
Shares of New York-based REITs fell about 5 percent on concerns over proposed rent freezes in the city, underscoring regulatory risks that could constrain revenue growth in rent-regulated segments (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2025.

Ventas Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Ventas Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VTR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs